Insider Transactions in Q1 2024 at Atri Cure, Inc. (ATRC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,885
-3.57%
|
$60,320
$32.16 P/Share
|
|
Mar 14
2024
|
Michael H Carrel President, CEO, & Director |
SELL
Bona fide gift
|
Direct |
2,000
-0.3%
|
-
|
|
Mar 12
2024
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.98%
|
$54,000
$36.72 P/Share
|
|
Mar 05
2024
|
Karl S. Dahlquist Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,231
-13.48%
|
$304,547
$37.36 P/Share
|
|
Mar 01
2024
|
Vinayak Doraiswamy Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,855
-13.04%
|
$318,780
$36.28 P/Share
|
|
Mar 01
2024
|
Vinayak Doraiswamy Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,622
+18.42%
|
-
|
|
Mar 01
2024
|
Douglas J Seith Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,596
-8.68%
|
$525,456
$36.28 P/Share
|
|
Mar 01
2024
|
Douglas J Seith Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,104
+15.27%
|
-
|
|
Mar 01
2024
|
Karl S. Dahlquist Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,281
+20.66%
|
-
|
|
Mar 01
2024
|
Angela L Wirick Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.47%
|
$80,000
$16.95 P/Share
|
|
Mar 01
2024
|
Angela L Wirick Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,469
+15.9%
|
-
|
|
Mar 01
2024
|
Michael H Carrel President, CEO, & Director |
SELL
Payment of exercise price or tax liability
|
Direct |
47,824
-6.78%
|
$1,721,664
$36.28 P/Share
|
|
Mar 01
2024
|
Michael H Carrel President, CEO, & Director |
BUY
Grant, award, or other acquisition
|
Direct |
119,996
+8.16%
|
-
|
|
Mar 01
2024
|
Deborah Lee Yount Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,056
-4.17%
|
-
|
|
Mar 01
2024
|
Deborah Lee Yount Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,294
+28.14%
|
-
|
|
Mar 01
2024
|
Salvatore Privitera Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,354
-6.96%
|
$264,744
$36.28 P/Share
|
|
Mar 01
2024
|
Salvatore Privitera Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,427
+11.35%
|
-
|
|
Mar 01
2024
|
Justin J Noznesky Chief Mktg & Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,856
-10.46%
|
$318,816
$36.28 P/Share
|
|
Mar 01
2024
|
Justin J Noznesky Chief Mktg & Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,622
+15.16%
|
-
|
|
Feb 23
2024
|
Robert S. White Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.1%
|
$150,000
$15.96 P/Share
|
|
Jan 04
2024
|
Shlomo Nachman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,322
+50.0%
|
-
|